Drug treatments for Alzheimer's disease.
作者信息
Kelly C A, Harvey R J, Cayton H
出版信息
BMJ. 1997 Mar 8;314(7082):693-4. doi: 10.1136/bmj.314.7082.693.
Abstract
摘要
相似文献
1
Drug treatments for Alzheimer's disease.阿尔茨海默病的药物治疗
BMJ. 1997 Mar 8;314(7082):693-4. doi: 10.1136/bmj.314.7082.693.
2
[The efficacy of donepezil hydrochloride on the Apathy scale in Alzheimer's disease].盐酸多奈哌齐对阿尔茨海默病患者淡漠量表评分的疗效
Nihon Ronen Igakkai Zasshi. 2010;47(5):481-2. doi: 10.3143/geriatrics.47.481.
3
Donepezil for Alzheimer's disease.多奈哌齐用于治疗阿尔茨海默病。
J Fam Pract. 1998 May;46(5):356.
4
Donepezil (Aricept) therapy for Alzheimer's disease.多奈哌齐（安理申）用于治疗阿尔茨海默病。
Compr Ther. 1997 Jul;23(7):492-3.
5
New drug treatments for Alzheimer disease.治疗阿尔茨海默病的新药疗法。
Arch Intern Med. 1998 May 11;158(9):941-2. doi: 10.1001/archinte.158.9.941.
6
Donepezil and Alzheimer's dementia.多奈哌齐与阿尔茨海默病性痴呆
Clin Perform Qual Health Care. 2000;8(1):47-51.
7
Cholinesterase inhibitors in Alzheimer's disease: donepezil or rivastigmine?阿尔茨海默病中的胆碱酯酶抑制剂：多奈哌齐还是卡巴拉汀？
Int J Clin Pract. 2002 Jul-Aug;56(6):414-5.
8
Galantamine vs donepezil in the treatment of Alzheimer's disease.加兰他敏与多奈哌齐治疗阿尔茨海默病的比较
Drugs Aging. 2003;20(15):1139-40; author reply 1140. doi: 10.2165/00002512-200320150-00009.
9
AD2000: donepezil in Alzheimer's disease.AD2000：多奈哌齐治疗阿尔茨海默病
Lancet. 2004 Jun 26;363(9427):2100-1. doi: 10.1016/S0140-6736(04)16533-1.
10
Response to letter from Garcia and colleagues on cholinesterase inhibitors and Alzheimer's disease outcomes.对加西亚及其同事关于胆碱酯酶抑制剂与阿尔茨海默病结局的来信的回应。
J Gerontol A Biol Sci Med Sci. 2007 Jun;62(6):679-80. doi: 10.1093/gerona/62.6.679.
引用本文的文献
1
Nanomedicine: A New Frontier in Alzheimer's Disease Drug Targeting.纳米医学：阿尔茨海默病药物靶向治疗的新前沿。
Cent Nerv Syst Agents Med Chem. 2025;25(1):3-19. doi: 10.2174/0118715249281331240325042642.
2
Citronellal as a Promising Candidate for Alzheimer's Disease Treatment: A Comprehensive Study on In Silico and In Vivo Anti-Acetylcholine Esterase Activity.香茅醛作为阿尔茨海默病治疗的潜在候选药物：关于计算机模拟和体内抗乙酰胆碱酯酶活性的综合研究
Metabolites. 2023 Nov 4;13(11):1133. doi: 10.3390/metabo13111133.
3
Identification of potential inhibitors against Alzheimer-related proteins in ethanol extract: experimental evidence and computational analyses.乙醇提取物中阿尔茨海默病相关蛋白潜在抑制剂的鉴定：实验证据与计算分析
3 Biotech. 2023 Sep;13(9):292. doi: 10.1007/s13205-023-03714-9. Epub 2023 Aug 4.
4
Combined ligand and structure-based virtual screening approaches for identification of novel AChE inhibitors.结合配体和基于结构的虚拟筛选方法以鉴定新型乙酰胆碱酯酶抑制剂。
Turk J Chem. 2020 Jun 1;44(3):574-588. doi: 10.3906/kim-1911-57. eCollection 2020.
5
The Volatile Chemical Compositions of the Essential Oil/SPME and Enzyme Inhibitory and Radical Scavenging Activities of Solvent Extracts and the Essential oils from Miller and L. grows in Turkey.土耳其生长的米勒和L.的精油/固相微萃取的挥发性化学成分以及溶剂提取物和精油的酶抑制和自由基清除活性
Iran J Pharm Res. 2019 Fall;18(4):1831-1842. doi: 10.22037/ijpr.2019.1100802.
6
Novel ligand-based docking; molecular dynamic simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for Alzheimer's disease.基于新型配体的对接；分子动力学模拟；以及用于分析阿尔茨海默病潜在乙酰胆碱酯酶抑制剂的吸收、分布、代谢和排泄方法。
J Pharm Anal. 2018 Dec;8(6):413-420. doi: 10.1016/j.jpha.2017.07.006. Epub 2017 Jul 14.
7
Novel N-allyl/propargyl tetrahydroquinolines: Synthesis via Three-component Cationic Imino Diels-Alder Reaction, Binding Prediction, and Evaluation as Cholinesterase Inhibitors.新型N-烯丙基/炔丙基四氢喹啉：通过三组分阳离子亚胺狄尔斯-阿尔德反应合成、结合预测及作为胆碱酯酶抑制剂的评价
Chem Biol Drug Des. 2016 Oct;88(4):498-510. doi: 10.1111/cbdd.12773. Epub 2016 Jun 6.
8
Analyses of the Binding between Water Soluble C60 Derivatives and Potential Drug Targets through a Molecular Docking Approach.通过分子对接方法分析水溶性C60衍生物与潜在药物靶点之间的结合。
PLoS One. 2016 Feb 1;11(2):e0147761. doi: 10.1371/journal.pone.0147761. eCollection 2016.
9
Development of dual inhibitors against Alzheimer's disease using fragment-based QSAR and molecular docking.基于片段的定量构效关系和分子对接开发抗阿尔茨海默病的双重抑制剂
Biomed Res Int. 2014;2014:979606. doi: 10.1155/2014/979606. Epub 2014 Jun 12.
10
7-Methoxytacrine-adamantylamine heterodimers as cholinesterase inhibitors in Alzheimer's disease treatment--synthesis, biological evaluation and molecular modeling studies.7-甲氧基他克林-金刚烷胺杂二聚体作为阿尔茨海默病治疗的乙酰胆碱酯酶抑制剂——合成、生物学评价和分子模拟研究。
Molecules. 2013 Feb 20;18(2):2397-418. doi: 10.3390/molecules18022397.
Zotero 插件